Express Scripts Holding Company (NASDAQ:ESRX) has received an average recommendation of “Hold” from the twenty-five brokerages that are currently covering the firm, Marketbeat reports. Six investment analysts have rated the stock with a sell rating, eleven have assigned a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company. The average 12-month price target among analysts that have updated their coverage on the stock in the last year is $69.34.

Several equities research analysts have recently weighed in on ESRX shares. BidaskClub upgraded Express Scripts Holding from a “sell” rating to a “hold” rating in a research note on Saturday, June 17th. Needham & Company LLC started coverage on Express Scripts Holding in a research note on Friday, July 21st. They issued a “hold” rating on the stock. Morgan Stanley upped their price objective on Express Scripts Holding from $52.00 to $57.00 and gave the company an “underweight” rating in a research note on Thursday, August 10th. Jefferies Group LLC set a $72.00 price objective on Express Scripts Holding and gave the company a “buy” rating in a research note on Tuesday, August 29th. Finally, Robert W. Baird reiterated a “hold” rating and issued a $56.00 price objective on shares of Express Scripts Holding in a research note on Friday, September 1st.

In other news, VP Phyllis S. Anderson sold 578 shares of the stock in a transaction on Friday, September 8th. The stock was sold at an average price of $63.13, for a total value of $36,489.14. Following the transaction, the vice president now owns 10,530 shares of the company’s stock, valued at approximately $664,758.90. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, VP Everett Neville sold 1,163 shares of the stock in a transaction on Wednesday, August 23rd. The shares were sold at an average price of $61.48, for a total value of $71,501.24. Following the completion of the transaction, the vice president now directly owns 18,232 shares in the company, valued at approximately $1,120,903.36. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 5,641 shares of company stock worth $357,317. Company insiders own 0.68% of the company’s stock.

Several hedge funds have recently bought and sold shares of the company. Vanguard Group Inc. lifted its stake in shares of Express Scripts Holding by 1.6% in the 1st quarter. Vanguard Group Inc. now owns 40,251,311 shares of the company’s stock valued at $2,652,964,000 after purchasing an additional 649,400 shares during the period. Dodge & Cox lifted its stake in shares of Express Scripts Holding by 25.7% in the 2nd quarter. Dodge & Cox now owns 36,188,517 shares of the company’s stock valued at $2,310,275,000 after purchasing an additional 7,388,021 shares during the period. State Street Corp lifted its stake in shares of Express Scripts Holding by 1.1% in the 1st quarter. State Street Corp now owns 27,060,709 shares of the company’s stock valued at $1,783,569,000 after purchasing an additional 298,341 shares during the period. Barrow Hanley Mewhinney & Strauss LLC lifted its stake in shares of Express Scripts Holding by 4.2% in the 1st quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 17,612,834 shares of the company’s stock valued at $1,160,862,000 after purchasing an additional 704,218 shares during the period. Finally, Macquarie Group Ltd. lifted its stake in shares of Express Scripts Holding by 8.4% in the 2nd quarter. Macquarie Group Ltd. now owns 11,880,919 shares of the company’s stock valued at $758,480,000 after purchasing an additional 922,406 shares during the period. 88.69% of the stock is currently owned by institutional investors.

TRADEMARK VIOLATION WARNING: “Express Scripts Holding Company (ESRX) Given Consensus Recommendation of “Hold” by Brokerages” was originally published by American Banking News and is the sole property of of American Banking News. If you are accessing this piece on another publication, it was illegally stolen and reposted in violation of international copyright legislation. The original version of this piece can be accessed at https://www.americanbankingnews.com/2017/10/12/express-scripts-holding-company-esrx-given-consensus-recommendation-of-hold-by-brokerages.html.

Express Scripts Holding (NASDAQ:ESRX) traded down 0.14% on Thursday, reaching $57.63. The company had a trading volume of 2,132,776 shares. The company has a 50-day moving average of $62.06 and a 200 day moving average of $62.53. Express Scripts Holding has a one year low of $57.41 and a one year high of $77.50. The stock has a market cap of $33.28 billion, a price-to-earnings ratio of 10.00 and a beta of 0.88.

Express Scripts Holding (NASDAQ:ESRX) last released its quarterly earnings data on Tuesday, July 25th. The company reported $1.73 earnings per share for the quarter, beating the consensus estimate of $1.71 by $0.02. Express Scripts Holding had a return on equity of 25.58% and a net margin of 3.50%. The company had revenue of $25.35 billion for the quarter, compared to analyst estimates of $25.52 billion. During the same period in the prior year, the company posted $1.57 EPS. The company’s revenue was up .5% compared to the same quarter last year. On average, equities research analysts predict that Express Scripts Holding will post $6.99 EPS for the current year.

Express Scripts Holding Company Profile

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Analyst Recommendations for Express Scripts Holding (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with MarketBeat.com's FREE daily email newsletter.